Skip to Content
Merck

Key Documents

View All Documentation

11-0720

Formaldehyde solution

JIS special grade, 36.0-38.0%, contains methanol as stabilizer

Synonym(s):

Formalin

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
HCHO
CAS Number:
50-00-0
Molecular Weight:
30.03
PubChem Substance ID:
329749309
UNSPSC Code:
41115710
Beilstein/REAXYS Number:
1209228
MDL number:
MFCD00003274
eCl@ss:
39021101
Grade:
JIS special grade
Bp:
97 °C ((37% solution) (lit.))
Vapor pressure:
52 mmHg ( 37 °C)
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

grade

JIS special grade

vapor density

1.03 (vs air)

vapor pressure

52 mmHg ( 37 °C)

form

liquid

autoignition temp.

572 °F

contains

methanol as stabilizer

availability

available only in Japan

concentration

36.0-38.0%

dilution

(for analytical testing)

bp

97 °C ((37% solution) (lit.))

mp

-15 °C (lit.)

density

1.09 g/mL at 25 °C (lit.)

application(s)

sample preparation

SMILES string

[H]C([H])=O

InChI

1S/CH2O/c1-2/h1H2

InChI key

WSFSSNUMVMOOMR-UHFFFAOYSA-N

Still not finding the right product?

Explore all of our products under Formaldehyde solution

signalword

Danger

Hazard Classifications

Acute Tox. 2 Inhalation - Acute Tox. 3 Dermal - Acute Tox. 3 Oral - Carc. 1B - Eye Dam. 1 - Muta. 2 - Skin Corr. 1B - Skin Sens. 1 - STOT SE 2 - STOT SE 3

target_organs

Eyes,Central nervous system, Respiratory system

Storage Class

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

wgk

WGK 3

flash_point_f

181.4 °F

flash_point_c

83 °C

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
U3630
J9556
J9551
J1338
J0247

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

James Larkin et al.
The New England journal of medicine, 373(1), 23-34 (2015-06-02)
Nivolumab (a programmed death 1 [PD-1] checkpoint inhibitor) and ipilimumab (a cytotoxic T-lymphocyte-associated antigen 4 [CTLA-4] checkpoint inhibitor) have been shown to have complementary activity in metastatic melanoma. In this randomized, double-blind, phase 3 study, nivolumab alone or nivolumab plus
Cindy S Ma et al.
The Journal of experimental medicine, 205(7), 1551-1557 (2008-07-02)
Hyper-immunoglobulin E syndrome (HIES) is a primary immune deficiency characterized by abnormal and devastating susceptibility to a narrow spectrum of infections, most commonly Staphylococcus aureus and Candida albicans. Recent investigations have identified mutations in STAT3 in the majority of HIES
Arpeeta Sharma et al.
Diabetes, 64(11), 3937-3950 (2015-06-28)
Patients with diabetes have an increased risk of developing atherosclerosis. Endothelial dysfunction, characterized by the lowered bioavailability of endothelial NO synthase (eNOS)-derived NO, is a critical inducer of atherosclerosis. However, the protective aspect of eNOS in diabetes-associated atherosclerosis remains controversial
View All Related Papers